Valiant Laboratories Ltd 15 May 2026 12:00 AM
Valiant Laboratories consolidated net profit rises 151.43% in the March 2026 quarter,
Net profit of Valiant Laboratories rose 151.43% to Rs 1.76 crore in the quarter ended March 2026 as against Rs 0.70 crore during the previous quarter ended March 2025. Sales rose 59.16% to Rs 91.98 crore in the quarter ended March 2026 as against Rs 57.79 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 3.27 crore in the year ended March 2026 as against net loss of Rs 2.20 crore during the previous year ended March 2025. Sales rose 78.04% to Rs 237.47 crore in the year ended March 2026 as against Rs 133.38 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales91.9857.79 59 237.47133.38 78 OPM %5.236.61 -2.69-3.50 - PBDT3.971.46 172 6.810.58 1074 PBT1.050.94 12 0.77-1.51 LP NP1.760.70 151 -3.27-2.20 -49 Powered by Capital Market - Live News
Valiant Laboratories Ltd 11 May 2026 12:00 AM
Valiant Laboratories to discuss results,
Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 14 May 2026.
Valiant Laboratories Ltd 11 Feb 2026 12:00 AM
Valiant Laboratories reports consolidated net loss of Rs 7.06 crore in the December 2025 quarter,
Net loss of Valiant Laboratories reported to Rs 7.06 crore in the quarter ended December 2025 as against net profit of Rs 2.35 crore during the previous quarter ended December 2024. Sales rose 48.91% to Rs 52.46 crore in the quarter ended December 2025 as against Rs 35.23 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales52.4635.23 49 OPM %-1.701.76 - PBDT-0.942.14 PL PBT-2.991.62 PL NP-7.062.35 PL Powered by Capital Market - Live News
Valiant Laboratories Ltd 06 Feb 2026 12:00 AM
Valiant Laboratories to hold board meeting,
Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News
Valiant Laboratories Ltd 12 Nov 2025 12:00 AM
Valiant Laboratories reports consolidated net profit of Rs 0.20 crore in the September 2025 quarter,
Net profit of Valiant Laboratories reported to Rs 0.20 crore in the quarter ended September 2025 as against net loss of Rs 4.74 crore during the previous quarter ended September 2024. Sales rose 115.08% to Rs 46.20 crore in the quarter ended September 2025 as against Rs 21.48 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales46.2021.48 115 OPM %0.15-31.38 - PBDT0.81-3.39 LP PBT0.28-3.91 LP NP0.20-4.74 LP Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now